Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company’s Bacteriophage Development Programs

/in

Link to Full Article MARINA DEL REY, Calif., Jan. 27, 2021 /PRNewswire/ — Armata Pharmaceuticals, Inc. (NYSE American: ARMP) (“Armata” or the “Company”), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that it has entered into a securities purchase agreement to sell Armata common stock and warrant securities to Innoviva […]

Read more

Saluda Medical Announces Highlights from 2021 North American Neuromodulation Society (NANS) Meeting

/in

Link to Full Article Artarmon, Australia – January 20, 2021 – Saluda Medical Pty Limited (“Saluda Medical”), the market leader in the development of closed-loop spinal cord stimulation for the treatment of chronic pain, announced scientific highlights from the 2021 North American Neuromodulation Society (NANS 2021) Virtual Meeting, including real-world European commercial results and sub-analyses of 24-month […]

Read more

Leading advocacy professionals to ensure patient remains central to Congenica’s approach

/in

Link to Full Article Cambridge, United Kingdom – 14 January 2021 – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announces the launch of a Patient Advocacy and Engagement Advisory Board. Working with the Congenica Board of Directors and wider senior leadership team, this group […]

Read more

Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China

/in

Link to Full Article Cambridge, United Kingdom – 12 January 2021 Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, today announced it has launched a local cloud solution that will enable researchers in China to perform more efficient genomic analysis at scale, helping to improve […]

Read more

Acrux receives FDA approval for its generic testosterone topical solution

/in

Link to Full Article Melbourne, Australia; 12 January 2021: Acrux Limited (ASX:ACR) (‘Acrux’ or the ‘Company’) is pleased to announce that the US Food and Drug Administration (‘FDA’) has approved its generic product based on Perrigo’s Testosterone Topical Solution, 30mg/1.5mL. In August 2018, Acrux submitted an Abbreviated New Drug Application (‘ANDA’) to seek approval from […]

Read more

Acrux (ASX:ACR) pushes ahead with $2M SPP

/in

Link to Full Article Acrux (ACR) is pushing ahead with its planned share purchase plan (SPP) sending off a booklet to eligible shareholders. The pharmaceutical company first flagged plans to carry out a fundraise back in late-December, when it successfully netted $7.8 million via a placement. ACR is now hoping to raise an additional $2 […]

Read more

GEN INCODE APPOINTS NEW CHAIRMAN

/in

Link to Full Article GENinCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the appointment of Bill Rhodes as non-executive Chairman of the Company, effective 1 January, 2021. Bill Rhodes is a Chairman with a proven, demonstrable international track record in the Life Sciences and […]

Read more

Destiny Pharma Phase 2b trial of XF-73 completes recruitment

/in

Link to Full Article Phase 2b clinical trial of XF-73 completes patient recruitment   Results expected in Q1 2021 Brighton, United Kingdom – 5th January 2021 – Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life threatening infections, today announces that its XF-73 […]

Read more

Loan Facility for Canary Medical Horizon Technology Finance and Silicon Valley Bank Provide $20 Million Venture

/in

Link to Full Article FARMINGTON, Conn., Jan. 4, 2021 /PRNewswire/ — Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, along with lending partner, Silicon Valley Bank (“SVB”), a provider […]

Read more

GEN INCODE APPOINTS NEW CHAIRMAN

/in

Link to Full Article GENinCode UK Limited the privately-owned artificial intelligence cardiovascular disease company focused on the prevention of cardiovascular disease, announces today the appointment of Bill Rhodes as non-executive Chairman of the Company, effective 1 January, 2021. Bill Rhodes is a Chairman with a proven, demonstrable international track record in the Life Sciences and […]

Read more